Cylert

Cylert was first approved by the FDA in 1975 and is used to treat Attention Deficit Hyperactive Disorder. Since it's approval, Cylert has been connected to 13 deaths.

A 1995 study indicated that Cylert increased the risk of liver failure in children by almost 45 times. At this point, the United Kingdom and Canada withdrew Cylert from the market. The FDA allowed Cylert's manufacturer, Abbot Laboratories, to continue selling Cylert if a good faith effort was made to collect necessary data, such as creating a patient registry those who had been prescribed Cylert. However, this registry was never created and Cylert remained on the U.S. market and millions of children were put at risk for its side effects.

Cylert's manufacturer recently halted sales of the drug upon pressure from public citizen's groups. However, millions of Americans have taken Cylert and could demonstrate the side effects of the drug.

If you or a loved one has been harmed by Cylert or another dangerous drug, please call or email our experienced Cylert side effects lawyers today. We'll evaluate your claim for free and help you get the justice you deserve.

For more information, please visit us at www.levinlaw.com


Home | Recent FDA Recalls | Other Dangerous Drugs | The FDA Approval Process | Frequently Asked Questions | FDA Recall News | About the Firm | Links | Site Map | Contact Us

Levin, Papantonio, Thomas, Mitchell,
Echsner & Proctor, P.A.
316 South Baylen Street, Suite 600
Pensacola, FL 32502-5996
toll free: (888) 435-7001, (850) 435-7000
fax: (850) 497-7057

Copyright Levin, Papantonio, Thomas, Mitchell,
Echsner & Proctor.
Pensacola, Florida Personal Injury Attorneys.
All Rights Reserved.

Disclaimer: Levin, Papantonio, Thomas, Mitchell, Echsner & Proctor Pensacola, dangerous drug lawyers provide the information in this web site for informational purposes only. The information does not constitute legal advice. The use of this site does not create an attorney-client relationship. Further communication with our personal injury attorneys through the web site and e-mail may not be considered as confidential or privileged. Please contact our defective pharmaceutical and medical device attorneys for a free evaluation of your claim.